Enzo Biochem Reports Favorable Delaware Court Markman Hearing Ruling

NEW YORK, NY -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that the United States District Court for the District of Delaware has issued a claim construction order governing ten ongoing patent litigations brought by Enzo against eleven companies regarding Enzo’s U.S. Patent Nos. 6,992,180; 7,064,197; and 8,097,405. In its claim construction ruling, the Court adopted [...]

Leica Microsystems Launches Laser Microdissection Microscope Series with LED for Transmitted Light

Wetzlar, Germany. Leica Microsystems has launched two instruments of the laser microdissection microscope series, the Leica LMD6 and the LMD7, with LED illumination for transmitted light. Users can now choose between halogen and LED illumination. LEDs are an energy-efficient light source providing homogenous illumination and a constant color temperature. They also save energy, and their [...]

InSphero AG Secures CHF 20 Million Series C Financing

Schlieren, Switzerland -- InSphero AG, the world’s leading developer of easy-to-use solutions for organotypic 3D cell culture models and body-on-a-chip systems, has secured CHF 20 million in financing from the family investment office of a globally active entrepreneur represented through HP WILD HOLDING AG based in Zug, Switzerland. InSphero is using the Series C financing [...]

QIAGEN expands QIAsymphony test menu in partnership with Seegene

HILDEN, Germany, and SEOUL, South Korea – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration in which Seegene Inc. (096530.KQ) will develop a menu of multiplex assay panels for its modular QIAsymphony RGQ MDx automation platform. The first project is to develop comprehensive panels to profile infectious diseases. Seegene’s proprietary technologies [...]

ASURAGEN LAUNCHES THE QUANTIDEX™ PAN CANCER KIT*, A WORKFLOW SOLUTION FOR TARGETED NEXT-GENERATION SEQUENCING

Austin, Texas –– Asuragen, Inc., a global molecular diagnostics company, announced today the launch of the Quantidex™ Pan Cancer Kit.* This next-generation sequencing (NGS) oncology panel offers a comprehensive workflow solution that integrates reagents, controls, and a novel bioinformatics suite for the sequencing of 21 genes relevant to a diverse set of human cancers. The [...]

Seven Bridges Genomics Funds Open Access to Bioinformatics Research

CAMBRIDGE, MA — Seven Bridges Genomics today announced a new program to pay the open access publication fees for any publication resulting from research conducted on its platform. Under the new program, called Open, any customer can quickly submit their information to be reimbursed for their open access fees through a simple online form. “We [...]

Smiths Group appoints new Chief Executive

Smiths Group plc is pleased to announce the appointment of Andrew Reynolds Smith as its new Chief Executive. He will join on 25 September 2015. Andrew, 49, is currently Chief Executive of GKN Automotive, the world’s leading manufacturer of driveline systems and powder metal components. With some £4.4bn of revenues and 31,000 employees across 22 [...]

Neogen signs commercialization agreement with Illumina

LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that it has signed an agreement to expand its relationship with Illumina (NASDAQ: ILMN), the global leader in sequencing and genomics. Under the agreement, Illumina will market and sell arrays with Neogen’s custom SNP content, built on Illumina Infinium® BeadArray technology, to the global agrigenomics community. [...]

ASTROTECH’S 1ST DETECT AWARDED PHASE II OF NEXT GENERATION CHEMICAL DETECTION SOLUTION

AUSTIN, Texas – 1st Detect Corporation, a subsidiary of Astrotech (Nasdaq:ASTC), announced today that its breakthrough portable mass spectrometer technology has reached another milestone in the Military’s three-phase, multi-year Next Generation Chemical Detector (NGCD) development program. Together with Battelle, 1st Detect has officially entered the phase II test and evaluation process for its prototype Multi-Sample [...]

Pistoia Alliance Continues to Attract New Members

Wilmington, DE -- The Pistoia Alliance, a global, not-for-profit alliance of organizations that work together to lower barriers to innovation in life science R&D, has attracted a number of new members from across the industry. New additions in the last quarter include another top ten pharmaceutical company joining as a Core member, and DNAnexus and [...]

Access IBO on Knowledge Center